Several genetic markers of human la molecules, each recognized by specific alloantisera, have been defined: DR1,2,3,4,5,w6,7,w8,w9,w10. They are controlled by a single locus, HLA-DR. In addition alloantigenic specificities have been identified which are associated, at the population level, with two or more of the above DR specificities. They have been called 'supertypic specificities'. DC1 supertypic specificity (nomenclature equivalents: MB1, MT1, LB12) has attracted particular attention, because although exhibiting a population association with DR1, 2 and w6, DC1 is carried by a different molecular species. Possibly, DC1 may represent the first genetic marker of a locus different from the DR locus but in strong linkage disequilibrium and therefore probably closely linked to it. Here we report the development of a monoclonal reagent specifically directed against DC1 and its utilization in a structural analysis of DC1 molecules as compared with la molecules carrying different DR determinants.

Human Ia molecules carrying DC1 determinants differ in both alpha- and beta-subunits from Ia molecules carrying DR determinants

Calabi F;
1981

Abstract

Several genetic markers of human la molecules, each recognized by specific alloantisera, have been defined: DR1,2,3,4,5,w6,7,w8,w9,w10. They are controlled by a single locus, HLA-DR. In addition alloantigenic specificities have been identified which are associated, at the population level, with two or more of the above DR specificities. They have been called 'supertypic specificities'. DC1 supertypic specificity (nomenclature equivalents: MB1, MT1, LB12) has attracted particular attention, because although exhibiting a population association with DR1, 2 and w6, DC1 is carried by a different molecular species. Possibly, DC1 may represent the first genetic marker of a locus different from the DR locus but in strong linkage disequilibrium and therefore probably closely linked to it. Here we report the development of a monoclonal reagent specifically directed against DC1 and its utilization in a structural analysis of DC1 molecules as compared with la molecules carrying different DR determinants.
1981
Istituto di Nanotecnologia - NANOTEC
Monoclonal antibody
HLA system
Histocompatibility Antigens Class II
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/216144
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 140
  • ???jsp.display-item.citation.isi??? ND
social impact